PUNE, India, March 15, 2022 /PRNewswire/ -- Chemistry analyzers are medical laboratory devices used to measure the concentration of particular compounds inside samples of serum, plasma, urine and other body fluids. Substances tested by these equipment include specific metabolites, electrolytes, proteins, and medicines. In today's shifting healthcare environment, laboratories all over the world are under pressure to improve patient care while lowering operating costs. It is one of the most essential aspects of clinical laboratory analysis, and clinical chemistry analyzer market has made significant progress in recent years. A wide range of tests, including diabetes testing, liver and kidney function, and electrolytes, as well as lipid profiles, thyroid testing, antibiotic drug level monitoring, and other drug level monitoring tests, can now be performed in the physician practice lab using an efficient, state-of-the-art chemistry analyzer. Leading manufacturers in the market are focused on providing a wide range of features such as interactive touch screen interface, advanced optics, on-board curve-fitting software, bichromatic and monochromatic reading, long-lasting IAD filters, and much more. In the recent decades, clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. Thus, such factors are driving the growth of the global clinical chemistry analyzer market.
Read our 420+ pages report on Medical Commodes Market published by Absolute Markets Insights
By Type
Automated clinical chemistry analyzers are gaining huge popularity as automation in clinical chemistry is resulting into higher volume of testing and a shorter turnaround time. When handled by laboratory specialists, the utilization of automated analyzers that can combine a variety of assays, assay types, reagents, software and peripherals provides a holistic package for enhancing clinical efficacy and outcomes. Moreover the automated analyzers improve user safety from biohazards and reduce the possibility of cross-contamination with an increased throughput. Leading players in the market are focused on incorporating advanced technologies into the analyzers. For instance, MNCHIP Technologies Co., Ltd. offers an automated clinical chemistry analyzer which has various built-in features such as a multi-test panel, improved visual experience with a touch screen display, a streamlined user interface and also equipped with a combined printer to print reports instantly. Thus with such advancements and automation the clinical chemistry analyzer market is flourishing globally.
Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1093
By End User
In the last few years there has been a rise in healthcare awareness amongst a large population which has led to rise in clinical testing. Testing of molecular functions is gaining popularity as these tests measure blood sugar, electrolyte, fluid balance, and kidney function which are vital for early detection of chronic diseases. Moreover the rising concerns about cardiac diseases has also led to an increased demand as these cardiac makers tests measure specific biological markers (biomarkers) in blood to detect various heart diseases. Clinical chemistry analyzers provide high throughput point-of-care solutions for the diagnosis of myocardial infarction and other cardiac-related diseases by measuring levels of STAT, cardiac troponin, CKM and CKB, myoglobin. Thus with the above factors mentioned the demand for clinical chemistry analyzer market is boosting globally.
Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1093
By Region
Asia Pacific is anticipated to be the fastest growing region in the clinical chemistry analyzer market for the forecast period. The geriatric population in countries like China, Japan and India is rapidly increasing which has led to rise in various age associated diseases such as hypertension, kidney issues, diabetes, liver problems and others. As these health problems require various tests such as basic metabolic panel, lipid profiles to be carried, the demand for clinical chemistry analyzers is thus rising in Asia Pacific.
Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1093
Global Clinical Chemistry Analyzer Market Research Scope:
Base Year |
2021 |
Historic Years |
2015 - 2020 |
Forecast Years |
2022 - 2030 |
Segments Covered |
By Measurement Technologies, Type, Substances, Photometric Throughput, Sample Load Capacity, Application, End User |
Quantitative Units |
Revenue in USD million/billion (2015 – 2030) and CAGR from 2022 to 2030 |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Countries Covered |
U.S., Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America |
Companies Profiled |
Abbott, Beckman Coulter, Inc., Cardinal Health, F. Hoffmann-La Roche Ltd., Hitachi High-Tech Corporation, HORIBA Medical, MNCHIP Technologies Co., Ltd., Siemens Healthcare GmbH, Randox Laboratories Ltd., Trivitron Healthcare, Thermo Fisher Scientific Inc amongst others. |
Report Coverage |
Market Determinants and Influencing Factors, Macro-Economic and Micro-Economic Indicators, Market Dynamics (Drivers, Restraints, Opportunities Challenges), Trends, Exclusive Details on the Effect of the Pandemic, Porter's Five Forces Analysis, Competitor Profiles and Landscape, Company Market Share Analysis, Product Benchmarking |
Customization Scope |
We offer the feasibility of customizing the reports specific to regions which will cover exclusive insights on regions and its respective countries. |
Add-Ons |
We offer our report in different languages which include German, French, Spanish, Japanese and Korean amongst others. |
View our exclusive press releases on Industry Global News24
Global Clinical Chemistry Analyzer Market:
- By Measurement Technologies
- Photometric and colorimetric testing
- Ion-selective potentiometry
- Latex agglutination
- Others
- By Type
- Automated
- Benchtop Analyzer
- Other
- By Substances
- Serum
- Plasma
- Urine
- Other body fluids
- By Photometric Throughput
- 400/800 with ISE
- 800/1,200 with ISE
- Up to 8,000 test/hour
- Up to 9,800 test/hour with dual ISE
- Others
- By Sample Load Capacity
- 80 (8 racks x 10 samples), 22 samples by carousel
- 150 (15 racks x 10 samples), 22 samples by carousel
- 400 samples (2 x 20 rack set)
- Others
- By Application
- Diabetes
- Testing for metabolic functions or cardiac markers
- Drugs-of-abuse testing
- Other
- By End User
- Physician Office Laboratory
- Hospital Laboratory
- Point-of-care clinics
- University and Research Institutes, Veterinary Laboratories and Food and Wine Laboratories
- Core Laboratory
- Reference Laboratory
- Integrated Delivery Network
- Others
Purchase the latest in-depth Clinical Chemistry Analyzer Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1093
Top Related Healthcare Categories:
- Point of Care (PoC) Lipid Test Market - In terms of revenue, point of care (PoC) lipid test market was valued at US$ 260.48 Mn in 2021 growing at a CAGR of 4.34% over the forecast period (2022 – 2030).
- Pregnancy Tests Market - In terms of revenue, global pregnancy tests market was valued at US$ 1444.68 Mn in 2019 and is anticipated to grow at a CAGR of 13.17% over the forecast period.
- Automated and Rapid Microbiological Tests Market - In terms of revenue, global pregnancy tests market was anticipated to grow at a CAGR of 22.12% over the forecast period.
- Molecular Diagnostics Market - Global molecular diagnostics market is expected to grow at CAGR 8.1% by 2029 owing to the rising demand for precision medicine application and COVID-19 applications.
- STD Diagnostics Market – In terms of revenue, global STD diagnostics market was valued at US$ 88706.7 Mn in 2018 and is anticipated to grow at a CAGR of 5.06% over the forecast period.
- Canine Lymphoma Treatment Market - Global canine lymphoma treatment market is expected to grow at a CAGR of 8% during the forecast period (2020-2028).
Glance through Absolute Markets Insights plethora of reports on Healthcare Category
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.
From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
SOURCE Absolute Markets Insights
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article